|
2020
|
Invention
|
Formulations.
Provided herein are high-dose formulations of acamprosate in a pharmaceutically ac... |
|
|
Invention
|
Formulations. Provided herein are high-dose formulations of acamprosate in a pharmaceutically acc... |
|
2019
|
Invention
|
Acamprosate formulations, methods of using the same, and combinations comprising the same.
Embod... |
|
2016
|
Invention
|
Methods of treating posttraumatic stress disorder with acamprosate salts. Embodiments disclosed h... |
|
2014
|
Invention
|
Acamprosate formulations, methods of using the same, and combinations comprising the same. Embodi... |
|
2006
|
Invention
|
Methods of treating tardive dyskinesia and other movement disorders. The present invention descri... |
|
2002
|
Invention
|
Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychi... |
|
1999
|
Invention
|
Methods of treating tardive dyskinesia and other movement disorders using nmda receptor antagonis... |
|
1998
|
Invention
|
Methods of treating tardive dyskinesia and other movement disorders. Disclosed is a method for tr... |
|
1997
|
Invention
|
Methods of treating tardive dyskinesia using nmda receptor antagonists. A method for treating sym... |
